C WorldWide Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-149,378
Closed -$3.06M 102
2019
Q1
$3.06M Hold
149,378
0.04% 76
2018
Q4
$1.88M Sell
149,378
-52,993
-26% -$790K 0.03% 83
2018
Q3
$3.11M Sell
202,371
-37,310
-16% -$516K 0.04% 82
2018
Q2
$3.14M Buy
239,681
+48,073
+25% +$529K 0.04% 83
2018
Q1
$1.56M Sell
191,608
-33,992
-15% -$275K 0.02% 89
2017
Q4
$2M Sell
225,600
-18,700
-8% -$172K 0.03% 84
2017
Q3
$2.72M Sell
244,300
-1,700
-0.7% -$16.5K 0.04% 84
2017
Q2
$2.2M Buy
+246,000
New +$1.95M 0.03% 94

Other funds holding NEO

C WorldWide Group's NEO Position: Q2 2019 in Review

C WorldWide Group sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 149,378 shares — an estimated $3.06M sold.

C WorldWide Group first reported a position in NEO in Q2 2017 and held it in 8 quarters. The position peaked at $3.14M in Q2 2018. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

  • C WorldWide Group reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 149,378 NeoGenomics shares in Q2 2019, an estimated $3.06M.
  • C WorldWide Group first reported a position in NeoGenomics in Q2 2017 and held it in 8 quarters.
  • C WorldWide Group's NeoGenomics position peaked at $3.14M in Q2 2018.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.